孤儿药称号-话题@MedSci - 梅斯（MedSci）

#孤儿药称号#

48篇内容 | 2366人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1365264, encodeId=6b331365264cf, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=梦想照进现实！二代NTRK抑制剂获FDA孤儿药称号, objectType=article, longId=731988, objectId=774ce3198835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=774ce3198835, replyNumber=0, likeNumber=89, createdTime=2022-07-12, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=774ce3198835, moduleTitle=梦想照进现实！二代NTRK抑制剂获FDA孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=774ce3198835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365263, encodeId=e0ef13652632d, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=FDA 授予 NT102治疗Dravet 综合征的孤儿药称号, objectType=article, longId=219585, objectId=2d9c219585b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d9c219585b5, replyNumber=0, likeNumber=80, createdTime=2021-11-02, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d9c219585b5, moduleTitle=FDA 授予 NT102治疗Dravet 综合征的孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2d9c219585b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365262, encodeId=c1e71365262ec, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=遗传性视网膜疾病，基因疗法OCU400获得欧盟“孤儿药称号”, objectType=article, longId=207573, objectId=78eb20e573ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78eb20e573ab, replyNumber=0, likeNumber=88, createdTime=2021-02-26, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78eb20e573ab, moduleTitle=遗传性视网膜疾病，基因疗法OCU400获得欧盟“孤儿药称号”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=78eb20e573ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365261, encodeId=5db7136526141, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=Sparsentan治疗IgA肾病（IgAN），EMA已授予Sparsentan“孤儿药称号”, objectType=article, longId=207390, objectId=460c20e390d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=460c20e390d3, replyNumber=0, likeNumber=170, createdTime=2021-02-22, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=460c20e390d3, moduleTitle=Sparsentan治疗IgA肾病（IgAN），EMA已授予Sparsentan“孤儿药称号”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=460c20e390d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365260, encodeId=73ea136526069, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=FDA授予SNF472治疗晚期肾脏疾病外周动脉疾病的“孤儿药称号”, objectType=article, longId=207051, objectId=f98220e051e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f98220e051e4, replyNumber=0, likeNumber=119, createdTime=2021-02-13, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f98220e051e4, moduleTitle=FDA授予SNF472治疗晚期肾脏疾病外周动脉疾病的“孤儿药称号”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f98220e051e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365259, encodeId=8bc3136525958, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=美国FDA授予Bcl-2抑制剂APG-2575第五个孤儿药称号，用以治疗滤泡性淋巴瘤（FL）, objectType=article, longId=206517, objectId=375420651efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=375420651efe, replyNumber=0, likeNumber=89, createdTime=2021-02-02, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=375420651efe, moduleTitle=美国FDA授予Bcl-2抑制剂APG-2575第五个孤儿药称号，用以治疗滤泡性淋巴瘤（FL）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=375420651efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365258, encodeId=d48813652589c, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=FDA授予MC-1治疗磷酸吡哆醇(胺)氧化酶(PNPO)缺乏症的“孤儿药称号”, objectType=article, longId=205513, objectId=71f620551356, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71f620551356, replyNumber=0, likeNumber=95, createdTime=2021-01-10, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71f620551356, moduleTitle=FDA授予MC-1治疗磷酸吡哆醇(胺)氧化酶(PNPO)缺乏症的“孤儿药称号”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=71f620551356)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365257, encodeId=55b2136525e94, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=FDA授予Ilixadencel治疗肝细胞癌（HCC）的“孤儿药称号”, objectType=article, longId=205226, objectId=9130205226b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9130205226b7, replyNumber=0, likeNumber=78, createdTime=2021-01-04, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9130205226b7, moduleTitle=FDA授予Ilixadencel治疗肝细胞癌（HCC）的“孤儿药称号”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9130205226b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365256, encodeId=b4cf1365256a3, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=Annamycin治疗软组织肉瘤，已获得FDA“孤儿药称号”, objectType=article, longId=205042, objectId=b142205042e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b142205042e2, replyNumber=0, likeNumber=94, createdTime=2021-01-01, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b142205042e2, moduleTitle=Annamycin治疗软组织肉瘤，已获得FDA“孤儿药称号”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b142205042e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365255, encodeId=9616136525591, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=FDA授予REV-0100治疗Stargardt病的孤儿药称号, objectType=article, longId=202655, objectId=6af8202655dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6af8202655dd, replyNumber=0, likeNumber=0, createdTime=2020-10-31, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6af8202655dd, moduleTitle=FDA授予REV-0100治疗Stargardt病的孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6af8202655dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365254, encodeId=fe2a136525406, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=FDA授予oNKord®治疗多发性骨髓瘤的“孤儿药称号”, objectType=article, longId=202036, objectId=bead202036d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bead202036d4, replyNumber=0, likeNumber=99, createdTime=2020-10-14, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bead202036d4, moduleTitle=FDA授予oNKord®治疗多发性骨髓瘤的“孤儿药称号”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bead202036d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365253, encodeId=b611136525369, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=神经母细胞瘤的治疗或迎突破性进展：Nivatrotamab获得FDA“孤儿药称号”和“罕见儿科疾病称号”, objectType=article, longId=201836, objectId=84d4201836d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84d4201836d0, replyNumber=0, likeNumber=67, createdTime=2020-10-10, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84d4201836d0, moduleTitle=神经母细胞瘤的治疗或迎突破性进展：Nivatrotamab获得FDA“孤儿药称号”和“罕见儿科疾病称号”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=84d4201836d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365252, encodeId=fffa136525253, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=FDA授予AT-007治疗PPM2-CDG的“孤儿药称号”, objectType=article, longId=201326, objectId=92fb201326c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92fb201326c6, replyNumber=0, likeNumber=125, createdTime=2020-09-30, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92fb201326c6, moduleTitle=FDA授予AT-007治疗PPM2-CDG的“孤儿药称号”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=92fb201326c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365251, encodeId=aa9a136525148, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=FDA授予基因疗法SPIRO-2101“孤儿药称号”，用于治疗囊性纤维化, objectType=article, longId=201259, objectId=dbba2012599b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbba2012599b, replyNumber=0, likeNumber=107, createdTime=2020-09-28, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbba2012599b, moduleTitle=FDA授予基因疗法SPIRO-2101“孤儿药称号”，用于治疗囊性纤维化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dbba2012599b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365250, encodeId=a48b136525021, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=基因疗法NR082治疗Leber遗传性视神经病变：FDA已授予孤儿药称号（ODD）, objectType=article, longId=201258, objectId=e1b12012586c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1b12012586c, replyNumber=0, likeNumber=123, createdTime=2020-09-28, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1b12012586c, moduleTitle=基因疗法NR082治疗Leber遗传性视神经病变：FDA已授予孤儿药称号（ODD）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e1b12012586c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365249, encodeId=d77d136524961, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=JR-141治疗亨特综合征：已获日本MHLW孤儿药称号, objectType=article, longId=200949, objectId=3ce120094921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ce120094921, replyNumber=0, likeNumber=83, createdTime=2020-09-21, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ce120094921, moduleTitle=JR-141治疗亨特综合征：已获日本MHLW孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3ce120094921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365248, encodeId=23151365248e1, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=大麻二酚（Cannabidiol）治疗22q11.2缺失综合症：已获FDA孤儿药称号, objectType=article, longId=200908, objectId=e5d6200908d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5d6200908d5, replyNumber=0, likeNumber=130, createdTime=2020-09-20, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5d6200908d5, moduleTitle=大麻二酚（Cannabidiol）治疗22q11.2缺失综合症：已获FDA孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e5d6200908d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365247, encodeId=8e93136524e19, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, objectType=article, longId=197668, objectId=c43e19e6680f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c43e19e6680f, replyNumber=0, likeNumber=109, createdTime=2020-07-19, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c43e19e6680f, moduleTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c43e19e6680f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365246, encodeId=af961365246ca, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=亚盛医药获得FDA授予第二个孤儿药称号：Bcl-2抑制剂APG-2575治疗华氏巨球蛋白血症, objectType=article, longId=197635, objectId=8f5319e6350c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f5319e6350c, replyNumber=0, likeNumber=81, createdTime=2020-07-18, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f5319e6350c, moduleTitle=亚盛医药获得FDA授予第二个孤儿药称号：Bcl-2抑制剂APG-2575治疗华氏巨球蛋白血症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8f5319e6350c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1365245, encodeId=f22313652458b, content=<a href='/topic/show?id=dfa045434e1' target=_blank style='color:#2F92EE;'>#孤儿药称号#</a>, objectTitle=NLRP3炎症小体抑制剂Inzomelid治疗自身炎症性疾病，获得FDA授予的孤儿药称号, objectType=article, longId=197598, objectId=b40919e5986b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b40919e5986b, replyNumber=0, likeNumber=112, createdTime=2020-07-17, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40919e5986b, moduleTitle=NLRP3炎症小体抑制剂Inzomelid治疗自身炎症性疾病，获得FDA授予的孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b40919e5986b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

孤儿药称号

2020-05-29

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

梦想照进现实！二代NTRK抑制剂获FDA孤儿药称号

2022-07-12

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

FDA 授予 NT102治疗Dravet 综合征的孤儿药称号

2021-11-02

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

遗传性视网膜疾病，基因疗法OCU400获得欧盟“孤儿药称号”

2021-02-26

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

Sparsentan治疗IgA肾病（IgAN），EMA已授予Sparsentan“孤儿药称号”

2021-02-22

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

FDA授予SNF472治疗晚期肾脏疾病外周动脉疾病的“孤儿药称号”

2021-02-13

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

美国FDA授予Bcl-2抑制剂APG-2575第五个孤儿药称号，用以治疗滤泡性淋巴瘤（FL）

2021-02-02

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

FDA授予MC-1治疗磷酸吡哆醇(胺)氧化酶(PNPO)缺乏症的“孤儿药称号”

2021-01-10

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

FDA授予Ilixadencel治疗肝细胞癌（HCC）的“孤儿药称号”

2021-01-04

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

Annamycin治疗软组织肉瘤，已获得FDA“孤儿药称号”

2021-01-01

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

FDA授予REV-0100治疗Stargardt病的孤儿药称号

2020-10-31

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

FDA授予oNKord®治疗多发性骨髓瘤的“孤儿药称号”

2020-10-14

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

神经母细胞瘤的治疗或迎突破性进展：Nivatrotamab获得FDA“孤儿药称号”和“罕见儿科疾病称号”

2020-10-10

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

FDA授予AT-007治疗PPM2-CDG的“孤儿药称号”

2020-09-30

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

FDA授予基因疗法SPIRO-2101“孤儿药称号”，用于治疗囊性纤维化

2020-09-28

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

基因疗法NR082治疗Leber遗传性视神经病变：FDA已授予孤儿药称号（ODD）

2020-09-28

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

JR-141治疗亨特综合征：已获日本MHLW孤儿药称号

2020-09-21

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

大麻二酚（Cannabidiol）治疗22q11.2缺失综合症：已获FDA孤儿药称号

2020-09-20

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号

2020-07-19

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

亚盛医药获得FDA授予第二个孤儿药称号：Bcl-2抑制剂APG-2575治疗华氏巨球蛋白血症

2020-07-18

huiwelcome (审核中...)

前往app查看评论内容

#孤儿药称号#

NLRP3炎症小体抑制剂Inzomelid治疗自身炎症性疾病，获得FDA授予的孤儿药称号

2020-07-17

科室
- - 订阅+
  - 更多科室
工具
服务